Recombinant SARS-CoV-2 Spike (Tixagevimab Biosimilar) antibody

Catalog No. ABIN7820519

The Human Monoclonal anti-SARS-CoV-2 Spike (Tixagevimab Biosimilar) antibody (ABIN7820519) specifically detects SARS-CoV-2 Spike (Tixagevimab Biosimilar). The antibody is reactive with SARS Coronavirus-2 (SARS-CoV-2) samples.

Quick Overview for Recombinant SARS-CoV-2 Spike (Tixagevimab Biosimilar) antibody (ABIN7820519)

Target: SARS-CoV-2 Spike (Tixagevimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: Human

Clonality: Monoclonal

Conjugate: Un-conjugated

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Tixagevimab Biosimilar - Anti-Covid Spike RBD mAb - Research Grade

Characteristics: IgG1, kappa

Isotype: IgG1, kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 0.01M PBS, pH 7.4.

Handling Advice: Avoid repeated freeze-thaw cycles

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles

Expiry Date: 12 months

Target Details

Target: SARS-CoV-2 Spike (Tixagevimab Biosimilar)

Alternative Name: Tixagevimab Biosimilar

Target Type: Biosimilar

Background: Anti-Spike Protein, Anti-RBD, AZD8895, COV2-2196,

UniProt: P0DTC2

CAS-No: CAS: 2420564-02-7